6 authorised products containing Lomitapide mesylate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Lojuxta 10 mg hard capsules EU/1/13/851/002 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
| Lojuxta 20 mg hard capsules EU/1/13/851/003 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
| Lojuxta 30 mg hard capsules EU/1/13/851/004 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
| Lojuxta 40 mg hard capsules EU/1/13/851/005 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
| Lojuxta 5 mg hard capsules EU/1/13/851/001 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
| Lojuxta 60 mg hard capsules EU/1/13/851/006 |
Lomitapide mesylate | Chiesi Farmaceutici S.p.A. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.